INTERNATIONAL PATENT: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING A MELANOMA ANTIGEN PREFERENTIALLY EXPRESSED IN TUMORS ANTIGEN AND METHODS OF USE"

GENEVA, May 19 -- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th St.Austin, Texas 78701) filed a patent application (PCT/US2024/054862) for "PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING A MELANOMA ANTIGEN PREFERENTIALLY EXPRESSED IN TUMORS ANTIGEN AND METHODS OF USE" on Nov 07, 2024. With publication no. WO/2025/101705, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PAN, Ke (c/o U.T.M.D. Anderson Cancer Center1515 Holcombe Blvd.Houston, Texas 77030), YEE, Cassian (c/o U.T.M.D. Anderson Cancer Center...